Myeloid-derived suppressor cells (MDSC) suppress the natural immune-response to tumor growth, and prevent the clinical effectiveness of immunotherapy against cancer. MDSC are induced by inflammation and mediate their effects by inhibiting the activation of tumor-reactive T-lymphocytes and by co-opting macrophage function. This project will identify molecular mechanisms by which MDSC recognize and attach to T- lymphocytes and macrophages, and illuminate the molecular connection between inflammation and cancer. Preliminary evidence supports the hypothesis that MDSC in tumor-bearing individuals receive signals promoting activation and accumulation through plasma membrane receptors. We will test this by identifying potential receptors and determining if activation through these receptors increases MDSC suppressive activity, and facilitates MDSC accumulation and/or retention. Protein expression/abundance will be compared quantitatively in MDS cells with low and high levels of inflammation from mice implanted with mammary carcinomas. New technologies will be implemented to enable facile isolation of the plasma membrane and extensive identification of surface receptors and other differentially expressed proteins. These include development of a heavy metal nanowire pellicle to simplify centrifugal isolation;elimination of gel electrophoresis with a chemical cleavage step;removal of bilayer lipids by magnetic nanotubes;and chemical and bioinformatic processing customized for mid-length peptides containing trans-membrane domains.
Recently a family of cells has been shown to suppress the body's natural immune-response to tumor growth, and also to prevent the effectiveness of cancer immunotherapy. This project will identify the mechanisms by which MDS cells recognize and attach to T lymphocytes and macrophages, and provide targets for intervention.
|Singh, Rajesh K; Kazansky, Yaniv; Wathieu, Donald et al. (2017) Hydrophobic Patch of Ubiquitin is Important for its Optimal Activation by Ubiquitin Activating Enzyme E1. Anal Chem 89:7852-7860|
|Ostrand-Rosenberg, Suzanne; Sinha, Pratima; Figley, Chas et al. (2017) Frontline Science: Myeloid-derived suppressor cells (MDSCs) facilitate maternal-fetal tolerance in mice. J Leukoc Biol 101:1091-1101|
|Lee, Amanda E; Geis-Asteggiante, Lucia; Dixon, Emma K et al. (2016) Preparing to read the ubiquitin code: top-down analysis of unanchored ubiquitin tetramers. J Mass Spectrom 51:629-637|
|Kim, Yeji; Edwards, Nathan; Fenselau, Catherine (2016) Extracellular vesicle proteomes reflect developmental phases of Bacillus subtilis. Clin Proteomics 13:6|
|Bronte, Vincenzo; Brandau, Sven; Chen, Shu-Hsia et al. (2016) Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. Nat Commun 7:12150|
|Castañeda, Carlos A; Dixon, Emma K; Walker, Olivier et al. (2016) Linkage via K27 Bestows Ubiquitin Chains with Unique Properties among Polyubiquitins. Structure 24:423-36|
|Lee, Amanda E; Geis-Asteggiante, Lucia; Dixon, Emma K et al. (2016) Preparing to read the ubiquitin code: characterization of ubiquitin trimers by top-down mass spectrometry. J Mass Spectrom 51:315-21|
|Ku, Amy W; Muhitch, Jason B; Powers, Colin A et al. (2016) Tumor-induced MDSC act via remote control to inhibit L-selectin-dependent adaptive immunity in lymph nodes. Elife 5:|
|Beury, Daniel W; Carter, Kayla A; Nelson, Cassandra et al. (2016) Myeloid-Derived Suppressor Cell Survival and Function Are Regulated by the Transcription Factor Nrf2. J Immunol 196:3470-8|
|Ostrand-Rosenberg, Suzanne (2016) Tolerance and immune suppression in the tumor microenvironment. Cell Immunol 299:23-9|
Showing the most recent 10 out of 104 publications